Reporting Segments

6 Months Ended

Jun. 30, 2011

Reporting Segments

Reporting Segments

NOTE J — Reporting Segments

The structure of the Company's internal organization is divided into the following three reportable segments: Energy and Chemicals ("E&C"), Distribution and Storage ("D&S") and BioMedical. The Company's reportable segments are business units that are each managed separately because they manufacture, offer and distribute distinct products with different production processes and sales and marketing approaches. The E&C segment sells brazed aluminum and air-cooled heat exchangers, cold boxes and liquefied natural gas vacuum-insulated pipe to natural gas, petrochemical processing and industrial gas companies who use them for the liquefaction and separation of natural and industrial gases. The D&S segment sells cryogenic bulk storage systems, cryogenic packaged gas systems, cryogenic systems and components, beverage liquid CO2 systems, cryogenic flow meter systems and cryogenic services to various companies for the storage and transportation of both industrial and natural gases. The BioMedical segment sells medical respiratory products, biological storage systems and other oxygen products. Due to the nature of the products that each segment sells, there are no intersegment sales. Corporate includes operating expenses for executive management, accounting, tax, treasury, human resources, information technology, legal, internal audit, risk management and stock-based compensation expenses that are not allocated to the reporting segments.

The Company evaluates performance and allocates resources based on operating income or loss from continuing operations before net interest expense, financing costs amortization expense, gain on acquisition of business, foreign currency gain or loss, income taxes and noncontrolling interest. The accounting policies of the reportable segments are described in the summary of significant accounting policies.

Information for the Company's three reportable segments and its corporate headquarters is presented below:

	Three Months Ended June 30, 2011
	Energy &  Chemicals		Distribution and Storage		BioMedical		Corporate			Total
Sales	$	49,121	$	101,682	$	49,895	$	—		$	200,698
Operating income (loss)		5,605		17,102		7,223		(8,441	)		21,489

	Six Months Ended June 30, 2011
	Energy &  Chemicals		Distribution and Storage		BioMedical		Corporate			Total
Sales	$	91,637	$	175,055	$	96,947	$	—		$	363,639
Operating income (loss)		9,357		28,622		15,670		(17,853	)		35,796

	Three Months Ended June 30, 2010
	Energy &  Chemicals			Distribution and Storage		BioMedical		Corporate			Total
Sales	$	31,381		$	68,146	$	39,617	$	—		$	139,144
Operating income (loss)		(866	)		10,402		6,499		(7,472	)		8,563

	Six Months Ended June 30, 2010
	Energy &  Chemicals			Distribution and Storage		BioMedical		Corporate			Total
Sales	$	57,562		$	127,113	$	72,737	$	—		$	257,412
Operating income (loss)		(1,130	)		19,325		12,100		(14,129	)		16,166